Experienced in Teratoma of the Mediastinum

Ur Metser

200 Elizabeth St, M5G, 2C4, 
Toronto, ON, CA 
Experienced in Teratoma of the Mediastinum
200 Elizabeth St, M5G, 2C4, 
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Ur Metser practices in Toronto, Canada. Metser is rated as an Experienced expert by MediFind in the treatment of Teratoma of the Mediastinum. Their top areas of expertise are Primary Mediastinal B-Cell Lymphoma (PMBCL), Prostate Cancer, Neuroendocrine Tumor, Cerebral Hypoxia, and Prostatectomy.

Their clinical research consists of co-authoring 165 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Teratoma of the Mediastinum.

Locations

200 Elizabeth St, M5G, 2C4, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR
Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR
Enrollment Status: Completed
Publish Date: June 25, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
Princess Margaret Cancer Centre 18F-DCFPyL PET Registry
Princess Margaret Cancer Centre 18F-DCFPyL PET Registry
Enrollment Status: Active_not_recruiting
Publish Date: March 28, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Combined 68Ga-DOTATATE and 18F-FDG PET/CT Imaging in Patients With Well-differentiated, G2-G3, Gastroenteropancreatic (GEP)-Neuroendocrine Tumors (NETs) - A Pilot Study
Combined 68Ga-DOTATATE and 18F-FDG PET/CT Imaging in Patients With Well-differentiated, G2-G3, Gastroenteropancreatic (GEP)-Neuroendocrine Tumors (NETs) - A Pilot Study
Enrollment Status: Active_not_recruiting
Publish Date: March 28, 2025
Intervention Type: Drug
Study Phase: Not Applicable
A Phase 3, Non-randomized, Open Label, Multi-centre Clinical Trial to Investigate the Safety and Efficacy of [18F]PSMA-1007 Injection in Men With Suspected Persistent or Recurrent Prostate Cancer.
A Phase 3, Non-randomized, Open Label, Multi-centre Clinical Trial to Investigate the Safety and Efficacy of [18F]PSMA-1007 Injection in Men With Suspected Persistent or Recurrent Prostate Cancer.
Enrollment Status: Completed
Publish Date: February 07, 2024
Intervention Type: Diagnostic test
Study Phase: Phase 3
18F-DCFPyL PET/CT in High-grade Epithelial Ovarian Cancer
18F-DCFPyL PET/CT in High-grade Epithelial Ovarian Cancer
Enrollment Status: Completed
Publish Date: November 02, 2022
Intervention Type: Diagnostic test
Study Phase: Not Applicable
PROPS (PET/MRI Pre-Radiotherapy for Post-Prostatectomy Salvage)
PROPS (PET/MRI Pre-Radiotherapy for Post-Prostatectomy Salvage)
Enrollment Status: Completed
Publish Date: April 05, 2022
Intervention Type: Device
Study Phase: Not Applicable
18F-Fluoroazomycin Arabinoside (FAZA) Positron Emission Tomography/Magnetic Imaging Resonance (PET/MRI) as a Biomarker of Hypoxia in Rectal Cancer: A Pilot Study
18F-Fluoroazomycin Arabinoside (FAZA) Positron Emission Tomography/Magnetic Imaging Resonance (PET/MRI) as a Biomarker of Hypoxia in Rectal Cancer: A Pilot Study
Enrollment Status: Completed
Publish Date: August 16, 2019
View 6 Less Clinical Trials

165 Total Publications

18F-FDG PET/CT of Oligometastatic Disease in Locally Advanced Breast Cancer: PETABC Trial Post Hoc Analysis.
18F-FDG PET/CT of Oligometastatic Disease in Locally Advanced Breast Cancer: PETABC Trial Post Hoc Analysis.
Journal: Radiology
Published: August 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Metser's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile